vck8sm5h Transcatheter Aortic Valve Implantation (TAVI) Reduces Mortality Rate Compared to Standard Therapy
The New England Journal of Medicine reported this month that, for patients with severe aortic stenosis who are not candidates for surgery, Transcatheter Aortic-Valve Implantation (TAVI) using the Edwards SAPIEN valve significantly reduced mortality compared to standard treatment. kdaesp1huv Transcatheter Aortic Valve Implantation (TAVI) Reduces Mortality Rate Compared to Standard TherapyAt one year, the rate of death from any cause was 30% with TAVI vs. 50.7% with standard treatment. However, this method had a higher incidence of strokes and major vascular complications compared to standard treatment.
The implantation procedure involves accessing a femoral artery, performing balloon valvuloplasty, then advancing the device across the native valve. During rapid right ventricular pacing, a balloon is inflated to deploy the valve and the frame.
Edwards is running another part of the trial comparing this valve with traditional open-heart aortic valve replacement.
Press release: The New England Journal of Medicine Publishes Transcatheter Heart Valve Trial Results
Abstract in NEJM: Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
Related: Edwards Receives Approval to Begin U.S. Clinical Trial of Next-Generation Transcatheter Valve
Product page: Edwards SAPIEN Transcatheter Heart Valve